1-Bromo-3-fluoro-5-nitrobenzene | CAS:7087-65-2

We serve 1-Bromo-3-fluoro-5-nitrobenzene CAS:7087-65-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-Bromo-3-fluoro-5-nitrobenzene

Chemical Name:1-Bromo-3-fluoro-5-nitrobenzene
CAS.NO:7087-65-2
Synonyms:1-Bromo-3-fluoro-5-nitrobenzene
3-Bromo-5-fluoronitrobenzene
3-Fluoro-5-nitrobromobenzene
 
Physical and Chemical Properties:
Density 1.8±0.1 g/cm3
Boiling Point 247.2±20.0 °C at 760 mmHg
Molecular Formula C6H5BrFN
Molecular Weight 219.996
Flash Point 103.3±21.8 °C
Appearance of Characters Liquid | Yellow
Vapour Pressure 0.0±0.5 mmHg at 25°C
Index of Refraction 1.580
 
Specification:
Appearance:Light brown liquid
Assay:≥97.0%
 
Packing:5 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 1-Bromo-3-fluoro-5-nitrobenzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Fluoro-5-nitrobromobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Fluoro-5-nitrobromobenzene Use and application,3-Bromo-5-fluoronitrobenzene technical grade,usp/ep/jp grade.


Related News: Authorities asked citizens not to leave the city unless there are special circumstances.2-Bromofluorobenzene manufacturer The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses.2-(4-(2-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)propan-2-yl)phenyl)ethanol supplier The patient, who arrived from Wuhan, is “stable and under medical care,” the ministry said in a statement, adding there is “no cause for concern” for the public.Ethyl 2-acetylhexanoate vendor “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.The company’s iPSC product platform unites stem cell biology and precision genetic engineering to create renewable master engineered iPSC lines that can be repeatedly used to mass produce cancer-fighting immune cells, replacing the high production costs, weeks of manufacturing time, and complex engineering processes required for current-generation CAR T-cell immunotherapies with an off-the-shelf product that has the potential to reach many more patients.